Concepedia

Lei Xing

LX

Statistics

Publications

90

Citations

5.7K

H-Index

44

Active since

2009

Affiliations

China Pharmaceutical University(Current)

The Affiliated Yongchuan Hospital of Chongqing Medical University

Chongqing Medical University

Zhongda Hospital Southeast University

Seoul National University

Lei Xing is an author at China Pharmaceutical University specializing in drug delivery, oncology, and pharmacy.

ORCID

Publications per year

2009–2025

90

Publications

90

The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer

Xiaying Zheng, Mengge Huang, Lei Xing et al. · Molecular Cancer · 2020 · 522 citations · Full text

, , +14

RETRACTED ARTICLE: The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression

Rui Yang, Lei Xing, Xiaying Zheng et al. · Molecular Cancer · 2019 · 378 citations · Full text

, , +17

Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator

Yujing He, Xiaoying Liu, Lei Xing et al. · Biomaterials · 2020 · 315 citations

, , +14

Coordination Polymer Coated Mesoporous Silica Nanoparticles for pH‐Responsive Drug Release

Lei Xing, Haoquan Zheng, Yuanyuan Cao et al. · Advanced Materials · 2012 · 241 citations

, , +17

Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10

Rui Yang, Hang Chen, Lei Xing et al. · Molecular Cancer · 2022 · 187 citations · Full text

, , +16

1–5 of 90